VC firm
Chiesi Ventures
- Investor type
- VC
- Investing status
- Activeas of 2026-09-22Source (opens in a new tab)
- Founded
- 2014
Claim, correct or request removal
Record updated 30 September 2026
About
Chiesi Ventures is a venture capital firm focused on the area of rare and orphan disorders. Our goal is to complement the strategic interest of the Chiesi Group by investing in early stage development opportunities. Chiesi Ventures also aim to accelerate the expansion of the Chiesi network in EU and the US among universities, venture capital investors, rare disease patient organizations and entrepreneurial companies developing treatments for rare diseases.
Investment approach
- Thesis
- We believe that one day every rare disease will be diagnosed rapidly and will have a cure, no matter how many rare diseases are there. Chiesi Ventures focuses on creating a better world by investing in promising start-ups that provide services and treatments for rare diseases.Source (opens in a new tab)
- Leads rounds
- Yes
- Lead policy
- With the deal, Chiesi Ventures is able to leverage A. M. Pappas & Associates’ expertise and network to access and assess deals and opportunities, lead investments and manage transactions
- Takes board seats
- Yes
- Board policy
- He serves as a Board Member or Observer on the Boards of the Chiesi Group, Chiesi USA, Sentien Biotech, Glycomine, Aura Bioscience and Minoryx Therapeutics.
- Eligibility
- Chiesi Ventures is a venture capital firm focused on the area of rare and orphan disorders.
- Investing status notes
- We appreciate your interest in Chiesi Ventures.
Loading relationship preview